Advanced Cell Technology Inc (OTCQB:ACTC.PK)

0.0637
Data as of Apr 17
 +0.0009 / +1.43%
Today’s Change
0.05
Today|||52-Week Range
0.10
+3.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$174.4M

Company Description

Advanced Cell Technology, Inc. is a biotechnology company that is focused on developing and commercializing human embryonic and adult stem cell technology in the emerging fields of regenerative medicine. The company has three cellular product platforms based on stem cell technology. It is focused on commercializing its human embryonic stem cell (hESC)-based Retinal Pigment Epithelial (RPE) therapy for degenerative retinal disease. The company is also developing its hESC-based Hemangioblast (HG) platform for the treatment of blood and cardiovascular diseases. Additionally it is developing a method for scaled manufacturing of Mesenchymal Stem Cells (MSCs) from renewable pluripotent stem cell sources. The company is also developing therapeutic platforms using Corneal Endothelial Cells for use in treating corneal blindness, as well as retinal neural progenitor cells for use in treating glaucoma. Advanced Cell Technology was founded on May 18, 2000 and is headquartered in Marlborough, MA.

Contact Information

Advanced Cell Technology, Inc.
33 Locke Drive
Marlborough Massachusetts 01752
P:(508) 756-1212
Investor Relations:

Employees

Shareholders

Individual stakeholders3.01%
Mutual fund holders--
Other institutional--

Top Executives

Edward H. MylesPresident, CFO & EVP-Corporate Development
Rita ParkerOperations Director
Eddy AngladeExecutive Vice President-Clinical Development
Robert P. LanzaChief Scientific Officer
Shi-Jiang LuSenior Director-Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.